Figure 1

Flowchart of patient’s enrollment. A total of 498 ICVD patients met the inclusion criteria. After excluding 44 patients with other stroke etiologies, 10 patients with arterial stenting, 13 patients who refused to participate, and 28 patients contraindicated or intolerant to CTA, finally, a total of 403 patients were included in the study.